Indeed Snapshot

Track Esperion Therapeutics reviews on Indeed to uncover insights on employee sentiment

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Profile Url Name Website Industry Description Revenue Headquarters location CEO Rating: CEO (%) Rating: CEO Responses Count Rating: Overall Happiness: Compensation score Happiness: Support score Happiness: Purpose score Happiness: Flexibility score Happiness: Energy score Happiness: Work Happiness score Happiness: Trust score Happiness: Learning score Happiness: Belonging score Happiness: Inclusion score Happiness: Overall score Happiness: Appreciation score Happiness: Achievement score Happiness: Responses Count Review Count Ratings Responses Count Rating: Culture & Values Rating: Compensation & Benefits Rating: Job Security & Advancement Rating: Senior Management Rating: Worklife Balance Interview: Duration Responses count Interview Duration Interview: Difficulty Responses count Interview Difficulty Interview: Experience Responses count Interview Experience Work Culture: Stressful (0) to Relaxed (1) Ratio Work Culture: Slow Paced (0) to Fast Paced (1) Ratio Work Culture: Competitive (0) to Collaborative (1) Ratio Date Added Date Updated Company Name Sector Industry
nasdaq:espr https://www.indeed.com/cmp/esperion-therapeutics,-inc.-1 Aug 29th, 2022 12:00AM Open Esperion Therapeutics Pharmaceutical & Biotechnology Singularly Focused on Lipid Management for Everybody In spite of advances in lipid management, millions of patients still find it difficult to reach their low‑density lipoprotein cholesterol (LDL-C) target. At ESPERION, we’re committed to changing that. Read about our mission and our core values. We have assembled a world-renowned team of lipid specialists who have been at the forefront of innovation in lipid management for decades. Our goal: to help patients who still need additional lipid lowering despite taking maximally tolerated statin therapy. With this goal in mind, we are driven to provide patients a novel treatment that not only works to lower LDL-C, but also works safely within their bodies. Every day, we are focused on this lone objective. Because we believe that to change this treatment paradigm, our company would rather be excellent in just this one disease state, than be good in several. Our approach is unprecedented in modern pharmaceuticals, and we think it is the right one. RRv1_UNDER_1M 3891 Ranchero Drive Suite 150 Ann Arbor, MI 48108 Sheldon Koenig 2.10 16.00 16.00 2.00 2.90 2.00 1.90 2.20 5.00 MEDIUM Aug 29th, 2022 11:55AM Aug 29th, 2022 11:55AM Esperion Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:espr https://www.indeed.com/cmp/esperion-therapeutics,-inc.-1 Aug 28th, 2022 12:00AM Open Esperion Therapeutics Pharmaceutical & Biotechnology Singularly Focused on Lipid Management for Everybody In spite of advances in lipid management, millions of patients still find it difficult to reach their low‑density lipoprotein cholesterol (LDL-C) target. At ESPERION, we’re committed to changing that. Read about our mission and our core values. We have assembled a world-renowned team of lipid specialists who have been at the forefront of innovation in lipid management for decades. Our goal: to help patients who still need additional lipid lowering despite taking maximally tolerated statin therapy. With this goal in mind, we are driven to provide patients a novel treatment that not only works to lower LDL-C, but also works safely within their bodies. Every day, we are focused on this lone objective. Because we believe that to change this treatment paradigm, our company would rather be excellent in just this one disease state, than be good in several. Our approach is unprecedented in modern pharmaceuticals, and we think it is the right one. RRv1_UNDER_1M 3891 Ranchero Drive Suite 150 Ann Arbor, MI 48108 Sheldon Koenig 2.10 16.00 16.00 2.00 2.90 2.00 1.90 2.20 5.00 MEDIUM Aug 28th, 2022 04:54AM Aug 28th, 2022 04:54AM Esperion Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:espr https://www.indeed.com/cmp/esperion-therapeutics,-inc.-1 Aug 27th, 2022 12:00AM Open Esperion Therapeutics Pharmaceutical & Biotechnology Singularly Focused on Lipid Management for Everybody In spite of advances in lipid management, millions of patients still find it difficult to reach their low‑density lipoprotein cholesterol (LDL-C) target. At ESPERION, we’re committed to changing that. Read about our mission and our core values. We have assembled a world-renowned team of lipid specialists who have been at the forefront of innovation in lipid management for decades. Our goal: to help patients who still need additional lipid lowering despite taking maximally tolerated statin therapy. With this goal in mind, we are driven to provide patients a novel treatment that not only works to lower LDL-C, but also works safely within their bodies. Every day, we are focused on this lone objective. Because we believe that to change this treatment paradigm, our company would rather be excellent in just this one disease state, than be good in several. Our approach is unprecedented in modern pharmaceuticals, and we think it is the right one. RRv1_UNDER_1M 3891 Ranchero Drive Suite 150 Ann Arbor, MI 48108 Sheldon Koenig 2.10 16.00 16.00 2.00 2.90 2.00 1.90 2.20 5.00 MEDIUM Aug 27th, 2022 04:14AM Aug 27th, 2022 04:14AM Esperion Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:espr https://www.indeed.com/cmp/esperion-therapeutics,-inc.-1 Aug 25th, 2022 12:00AM Open Esperion Therapeutics Pharmaceutical & Biotechnology Singularly Focused on Lipid Management for Everybody In spite of advances in lipid management, millions of patients still find it difficult to reach their low‑density lipoprotein cholesterol (LDL-C) target. At ESPERION, we’re committed to changing that. Read about our mission and our core values. We have assembled a world-renowned team of lipid specialists who have been at the forefront of innovation in lipid management for decades. Our goal: to help patients who still need additional lipid lowering despite taking maximally tolerated statin therapy. With this goal in mind, we are driven to provide patients a novel treatment that not only works to lower LDL-C, but also works safely within their bodies. Every day, we are focused on this lone objective. Because we believe that to change this treatment paradigm, our company would rather be excellent in just this one disease state, than be good in several. Our approach is unprecedented in modern pharmaceuticals, and we think it is the right one. RRv1_UNDER_1M 3891 Ranchero Drive Suite 150 Ann Arbor, MI 48108 Sheldon Koenig 2.10 16.00 16.00 2.00 2.90 2.00 1.90 2.20 5.00 MEDIUM Aug 25th, 2022 08:53AM Aug 25th, 2022 08:53AM Esperion Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:espr https://www.indeed.com/cmp/esperion-therapeutics,-inc.-1 Aug 23rd, 2022 12:00AM Open Esperion Therapeutics Pharmaceutical & Biotechnology Singularly Focused on Lipid Management for Everybody In spite of advances in lipid management, millions of patients still find it difficult to reach their low‑density lipoprotein cholesterol (LDL-C) target. At ESPERION, we’re committed to changing that. Read about our mission and our core values. We have assembled a world-renowned team of lipid specialists who have been at the forefront of innovation in lipid management for decades. Our goal: to help patients who still need additional lipid lowering despite taking maximally tolerated statin therapy. With this goal in mind, we are driven to provide patients a novel treatment that not only works to lower LDL-C, but also works safely within their bodies. Every day, we are focused on this lone objective. Because we believe that to change this treatment paradigm, our company would rather be excellent in just this one disease state, than be good in several. Our approach is unprecedented in modern pharmaceuticals, and we think it is the right one. RRv1_UNDER_1M 3891 Ranchero Drive Suite 150 Ann Arbor, MI 48108 Sheldon Koenig 2.10 16.00 16.00 2.00 2.90 2.00 1.90 2.20 5.00 MEDIUM Aug 23rd, 2022 10:47AM Aug 23rd, 2022 10:47AM Esperion Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:espr https://www.indeed.com/cmp/esperion-therapeutics,-inc.-1 Aug 21st, 2022 12:00AM Open Esperion Therapeutics Pharmaceutical & Biotechnology Singularly Focused on Lipid Management for Everybody In spite of advances in lipid management, millions of patients still find it difficult to reach their low‑density lipoprotein cholesterol (LDL-C) target. At ESPERION, we’re committed to changing that. Read about our mission and our core values. We have assembled a world-renowned team of lipid specialists who have been at the forefront of innovation in lipid management for decades. Our goal: to help patients who still need additional lipid lowering despite taking maximally tolerated statin therapy. With this goal in mind, we are driven to provide patients a novel treatment that not only works to lower LDL-C, but also works safely within their bodies. Every day, we are focused on this lone objective. Because we believe that to change this treatment paradigm, our company would rather be excellent in just this one disease state, than be good in several. Our approach is unprecedented in modern pharmaceuticals, and we think it is the right one. RRv1_UNDER_1M 3891 Ranchero Drive Suite 150 Ann Arbor, MI 48108 Sheldon Koenig 2.10 16.00 16.00 2.00 2.90 2.00 1.90 2.20 5.00 MEDIUM Aug 21st, 2022 12:30PM Aug 21st, 2022 12:30PM Esperion Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:espr https://www.indeed.com/cmp/esperion-therapeutics,-inc.-1 Aug 20th, 2022 12:00AM Open Esperion Therapeutics Pharmaceutical & Biotechnology Singularly Focused on Lipid Management for Everybody In spite of advances in lipid management, millions of patients still find it difficult to reach their low‑density lipoprotein cholesterol (LDL-C) target. At ESPERION, we’re committed to changing that. Read about our mission and our core values. We have assembled a world-renowned team of lipid specialists who have been at the forefront of innovation in lipid management for decades. Our goal: to help patients who still need additional lipid lowering despite taking maximally tolerated statin therapy. With this goal in mind, we are driven to provide patients a novel treatment that not only works to lower LDL-C, but also works safely within their bodies. Every day, we are focused on this lone objective. Because we believe that to change this treatment paradigm, our company would rather be excellent in just this one disease state, than be good in several. Our approach is unprecedented in modern pharmaceuticals, and we think it is the right one. RRv1_UNDER_1M 3891 Ranchero Drive Suite 150 Ann Arbor, MI 48108 Sheldon Koenig 2.10 16.00 16.00 2.00 2.90 2.00 1.90 2.20 5.00 MEDIUM Aug 20th, 2022 02:07PM Aug 20th, 2022 02:07PM Esperion Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:espr https://www.indeed.com/cmp/esperion-therapeutics,-inc.-1 Aug 19th, 2022 12:00AM Open Esperion Therapeutics Pharmaceutical & Biotechnology Singularly Focused on Lipid Management for Everybody In spite of advances in lipid management, millions of patients still find it difficult to reach their low‑density lipoprotein cholesterol (LDL-C) target. At ESPERION, we’re committed to changing that. Read about our mission and our core values. We have assembled a world-renowned team of lipid specialists who have been at the forefront of innovation in lipid management for decades. Our goal: to help patients who still need additional lipid lowering despite taking maximally tolerated statin therapy. With this goal in mind, we are driven to provide patients a novel treatment that not only works to lower LDL-C, but also works safely within their bodies. Every day, we are focused on this lone objective. Because we believe that to change this treatment paradigm, our company would rather be excellent in just this one disease state, than be good in several. Our approach is unprecedented in modern pharmaceuticals, and we think it is the right one. RRv1_UNDER_1M 3891 Ranchero Drive Suite 150 Ann Arbor, MI 48108 Sheldon Koenig 2.10 16.00 16.00 2.00 2.90 2.00 1.90 2.20 5.00 MEDIUM Aug 19th, 2022 12:30PM Aug 19th, 2022 12:30PM Esperion Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:espr https://www.indeed.com/cmp/esperion-therapeutics,-inc.-1 Aug 18th, 2022 12:00AM Open Esperion Therapeutics Pharmaceutical & Biotechnology Singularly Focused on Lipid Management for Everybody In spite of advances in lipid management, millions of patients still find it difficult to reach their low‑density lipoprotein cholesterol (LDL-C) target. At ESPERION, we’re committed to changing that. Read about our mission and our core values. We have assembled a world-renowned team of lipid specialists who have been at the forefront of innovation in lipid management for decades. Our goal: to help patients who still need additional lipid lowering despite taking maximally tolerated statin therapy. With this goal in mind, we are driven to provide patients a novel treatment that not only works to lower LDL-C, but also works safely within their bodies. Every day, we are focused on this lone objective. Because we believe that to change this treatment paradigm, our company would rather be excellent in just this one disease state, than be good in several. Our approach is unprecedented in modern pharmaceuticals, and we think it is the right one. RRv1_UNDER_1M 3891 Ranchero Drive Suite 150 Ann Arbor, MI 48108 Sheldon Koenig 2.10 16.00 16.00 2.00 2.90 2.00 1.90 2.20 Aug 18th, 2022 04:14AM Aug 18th, 2022 04:14AM Esperion Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:espr https://www.indeed.com/cmp/esperion-therapeutics,-inc.-1 Aug 17th, 2022 12:00AM Open Esperion Therapeutics Pharmaceutical & Biotechnology Singularly Focused on Lipid Management for Everybody In spite of advances in lipid management, millions of patients still find it difficult to reach their low‑density lipoprotein cholesterol (LDL-C) target. At ESPERION, we’re committed to changing that. Read about our mission and our core values. We have assembled a world-renowned team of lipid specialists who have been at the forefront of innovation in lipid management for decades. Our goal: to help patients who still need additional lipid lowering despite taking maximally tolerated statin therapy. With this goal in mind, we are driven to provide patients a novel treatment that not only works to lower LDL-C, but also works safely within their bodies. Every day, we are focused on this lone objective. Because we believe that to change this treatment paradigm, our company would rather be excellent in just this one disease state, than be good in several. Our approach is unprecedented in modern pharmaceuticals, and we think it is the right one. RRv1_UNDER_1M 3891 Ranchero Drive Suite 150 Ann Arbor, MI 48108 Sheldon Koenig 2.10 16.00 16.00 2.00 2.90 2.00 1.90 2.20 Aug 17th, 2022 09:53AM Aug 17th, 2022 09:53AM Esperion Therapeutics Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.